Related Experiment Videos
Proliferating cell nuclear antigen. A marker for cell proliferation in autopsy tissues
F F Isik1, M Ferguson, E Yamanaka
1Department of Pathology, University of Washington School of Medicine, Seattle.
Archives of Pathology & Laboratory Medicine
|November 1, 1992
Summary
Proliferating cell nuclear antigen (PCNA) antibodies reliably identify proliferating cells in autopsy tissues up to 12 hours postmortem. Sensitivity decreases over time, with skin being an exception, but PCNA staining remains feasible for research.
Area of Science:
- Cellular Biology
- Pathology
- Immunohistochemistry
Background:
- Proliferating cell nuclear antigen (PCNA) antibodies are used to identify proliferating cells in fresh tissues.
- Reliability of PCNA antibodies in autopsy-derived tissues, with postmortem delays, is not well-established.
Purpose of the Study:
- To assess the reliability of anti-PCNA antibodies for identifying proliferating cells in autopsy tissue specimens.
- To determine the impact of postmortem interval on PCNA staining in various tissues.
Main Methods:
- An autopsy simulation was performed using fresh monkey and rat tissues.
- Tissues were kept at room temperature for varying durations before fixation.
- Immunocytochemical methods using anti-PCNA antibodies were applied.
Main Results:
- PCNA staining was most reliable within 6 hours postmortem.
- Reliable staining persisted up to 12 hours, with decreased sensitivity.
- Skin showed reliable staining after longer postmortem intervals.
- Quantitative analysis of monkey spleen showed a decrease in PCNA-positive cells from 63% (immediate fixation) to 19% (18 hours postmortem).
- Human autopsy tissues exhibited similar postmortem staining patterns.
Conclusions:
- Anti-PCNA antibodies can identify proliferating cells in human autopsy tissues obtained within approximately 12 hours of death.
- Rapid tissue procurement and fixation are recommended.
- Control tissues from the same autopsy (e.g., lymph node) are advised.
- Overall sensitivity may be compromised with longer postmortem intervals.